Michigan State: Nanomedicine Targets Cardiovascular Disease
January 09, 2021
January 09, 2021
EAST LANSING, Michigan, Jan. 9 (TNSJou) -- Michigan State University issued the following news release:
Michigan State and Stanford researchers have upgraded their Trojan horse therapies designed to fight one of the world's leading causes of death.
Led by Bryan Smith, an associate professor in MSU's Department of Biomedical Engineering, the team is building on its nanoscopic tubules that carry drugs to fight atherosclerotic plaques involved in cardiovascular d . . .
Michigan State and Stanford researchers have upgraded their Trojan horse therapies designed to fight one of the world's leading causes of death.
Led by Bryan Smith, an associate professor in MSU's Department of Biomedical Engineering, the team is building on its nanoscopic tubules that carry drugs to fight atherosclerotic plaques involved in cardiovascular d . . .